First Houston Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$761K Buy
10,500
+1,400
+15% +$94.1K 0.76% 44
2017
Q1
$593K Buy
9,100
+200
+2% +$12.6K 0.55% 53
2016
Q4
$557K Sell
8,900
-11,500
-56% -$702K 0.54% 53
2016
Q3
$1.29M Buy
20,400
+1,300
+7% +$84.2K 1.3% 37
2016
Q2
$1.18M Buy
19,100
+4,300
+29% +$262K 1.09% 42
2016
Q1
$845K Buy
14,800
+6,700
+83% +$373K 0.81% 47
2015
Q4
$480K Sell
8,100
-2,700
-25% -$156K 0.44% 60
2015
Q3
$588K Sell
10,800
-100
-0.9% -$6.51K 0.56% 53
2015
Q2
$638K Hold
10,900
0.57% 51
2015
Q1
$638K Hold
10,900
0.56% 53
2014
Q4
$713K Buy
10,900
+1,600
+17% +$101K 0.63% 50
2014
Q3
$537K Buy
9,300
+300
+3% +$16.7K 0.5% 46
2014
Q2
$508K Buy
9,000
+100
+1% +$5.25K 0.49% 43
2014
Q1
$457K Buy
8,900
+200
+2% +$10.1K 0.45% 44
2013
Q4
$459K Sell
8,700
-500
-5% -$24.6K 0.45% 50
2013
Q3
$412K Buy
+9,200
New +$408K 0.44% 52

Other funds holding ABBV

First Houston Capital's ABBV Position: Q2 2017 in Review

First Houston Capital increased its AbbVie (ABBV) stake by 15% in Q2 2017, buying an estimated $94.1K and bringing the position to 10,500 shares worth $761K. The position accounts for 0.76% of the portfolio, ranked #44.

First Houston Capital first reported a position in ABBV in Q3 2013 and has held it in 16 quarters since. The position peaked at $1.29M in Q3 2016. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • First Houston Capital held 10,500 shares of AbbVie worth $761K as of Q2 2017.
  • First Houston Capital bought 1,400 AbbVie shares in Q2 2017, an estimated $94.1K.
  • AbbVie made up 0.76% of First Houston Capital's portfolio in Q2 2017, its #44 holding.
  • First Houston Capital first reported a position in AbbVie in Q3 2013 and has held it in 16 quarters since.
  • First Houston Capital's AbbVie position peaked at $1.29M in Q3 2016.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on First Houston Capital's 13F filing for Q2 2017, filed 7 Aug 2017.